How severe is CVE-2023-22527?

No CVSS score has been assigned to CVE-2023-22527 yet. Review the advisory details and affected package list to assess your exposure.

Which products are affected by CVE-2023-22527?

CVE-2023-22527 affects the following products: atlassian confluence data center, atlassian confluence server.

How do I patch CVE-2023-22527?

No patch has shipped for CVE-2023-22527 yet — track the atlassian confluence data center advisory for a fixed release and apply the workarounds below in the meantime.

How do I detect CVE-2023-22527 across my infrastructure?

Inventory every atlassian confluence data center deployment and check each version against the affected-products list above.

How do I mitigate CVE-2023-22527 if there is no patch (or I can't update yet)?

If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands. Alongside that, restrict the management interface to trusted networks and apply the vendor's recommended configuration mitigations.

Is CVE-2023-22527 actively exploited in the wild?

Yes. There are 35 known exploit references for CVE-2023-22527, including 20 in-the-wild exploitations observed on GitHub and other sources. Treat this as actively exploitable and prioritize patching immediately. All exploit code should only be run in an isolated sandbox environment for research or authorized testing — never against production systems without explicit written authorization.

What is the EPSS score for CVE-2023-22527?

CVE-2023-22527 has an EPSS (Exploit Prediction Scoring System) score of 100.0%, placing it in the 100th percentile of all CVEs. EPSS is maintained by FIRST.org and estimates the probability that a vulnerability will be exploited in the wild within the next 30 days. A score above 50% indicates significantly elevated exploitation risk — immediate patching is strongly recommended.

Is CVE-2023-22527 in the CISA Known Exploited Vulnerabilities catalog?

Yes. CVE-2023-22527 (Atlassian Confluence Data Center and Server Template Injection Vulnerability) was added to CISA's Known Exploited Vulnerabilities (KEV) catalog on 2024-01-24. CISA required all US federal civilian agencies to remediate this vulnerability by 2024-02-14. The required action was: Apply mitigations per vendor instructions or discontinue use of the product if mitigations are unavailable. This CVE has been used in known ransomware campaigns. Being listed in the KEV catalog is the strongest possible confirmation of active exploitation — treat this as a critical priority.

What type of vulnerability is CVE-2023-22527?

CVE-2023-22527 is classified as CWE-74 (CWE-74). This weakness type describe the underlying flaw category, which helps determine the potential impact and the right class of mitigation.

Which products and versions are affected by CVE-2023-22527?

CVE-2023-22527 affects atlassian confluence data center (1 version, e.g. 8.0.0); atlassian confluence server (1 version, e.g. 8.0.0). Check the affected-products list on this page against your deployed version to confirm exposure.

Is there exploit tooling available for CVE-2023-22527?

A Nuclei detection template exists for CVE-2023-22527, meaning automated scanners can fingerprint it. Public exploit tooling significantly increases real-world risk — prioritize patching and ensure detection coverage. Exploit tooling should only ever be used in isolated, authorized testing environments.

When was CVE-2023-22527 published, and has it been updated?

CVE-2023-22527 was published on January 16, 2024 and was last updated on October 21, 2025. Advisory data evolves as severity scores, affected ranges, and exploit intelligence are revised — always check the latest version of the advisory before acting.

CISA KEV · ACTIVELY EXPLOITED

CVE-2023-22527 — Confluence Data Center

CVE-2023-22527 is a CWE-74 vulnerability in atlassian confluence data center. It is in CISA's Known Exploited Vulnerabilities catalog (added 2024-01-24) and has been used in ransomware campaigns — treat it as actively exploited and patch now. No vendor fix is recorded yet; mitigation options are listed below.

A template injection vulnerability on older versions of Confluence Data Center and Server allows an unauthenticated attacker to achieve RCE on an affected instance. Customers using…

Published

Jan 16, 2024

Updated

Oct 21, 2025

Affected

2 products

Patched

See advisory

Exploits

35 known

Exploitation data as of Oct 22, 2026 · OSV.dev, NVD, CISA KEV, FIRST.org (EPSS)

Exploitation Status

Actively exploited in the wild

Confirmed by CISA's Known Exploited Vulnerabilities catalog on 2024-01-24 — including use in ransomware campaigns. Federal agencies were required to remediate by 2024-02-14.
CISA assesses this as automatable — exploitation doesn’t require manual, per-target effort, which raises the odds of mass scanning and opportunistic attacks.
A successful exploit gives an attacker total control of the affected component, not partial access.

Exploitation and automatability from CISA (KEV catalog and SSVC triage) for CVE-2023-22527.

EPSS Exploitation Probability

via FIRST.org ↗

100.0%probability of exploitation in next 30 days

Very High Risk0.00%

Lower risk than most CVEs100th percentile — riskier than 100% of all scored CVEsHighest risk

Probability of exploitation in the next 30 days, from FIRST.org EPSS.

Description

Most recent supported versions of Confluence Data Center and Server are not affected by this vulnerability as it was ultimately mitigated during regular version updates. However, Atlassian recommends that customers take care to install the latest version to protect their instances from non-critical vulnerabilities outlined in Atlassian’s January Security Bulletin.

Affected Products

2 products · 2 configurations

Application

confluence data centeratlassian

1 version

8.0.0

Application

confluence serveratlassian

1 version

8.0.0

Exploits & PoCs

Research use only. For defensive security, authorized penetration testing, and academic research only. Never execute exploit code against systems without explicit written authorization.